CG Oncology(CGON) - 2025 Q4 - Annual Results

Exhibit 99.1 CG Oncology Reports 2025 Year End Financial Results and Provides Business Updates IRVINE, Calif., February 27, 2026 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON) today reported financial results for the fourth quarter and year ended December 31, 2025, and provided business updates. "In the coming months, we look forward to sharing topline data from PIVOT-006, the first randomized registrational trial to evaluate an investigational therapy in intermediate-risk NMIBC. We believe we have th ...